NPHC — Nutra Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- $0.72m
- $15.06m
- $0.39m
Annual cashflow statement for Nutra Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.1 | 8.18 | -1.39 | -1.29 | -2.05 |
| Depreciation | |||||
| Non-Cash Items | 11.2 | -10.2 | 0.463 | 0.402 | 0.657 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.121 | 1.19 | 0.363 | 0.453 | 0.216 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -1.74 | -0.762 | -0.55 | -0.424 | -1.16 |
| Capital Expenditures | -0.039 | -0.058 | — | — | -0.026 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.255 | 0.085 | 0.117 | 0.041 | -0.025 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.294 | 0.027 | 0.117 | 0.041 | -0.051 |
| Financing Cash Flow Items | -0.077 | -0.164 | 0.437 | 0.323 | 0.353 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.13 | 0.644 | 0.433 | 0.419 | 1.19 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.091 | -0.091 | 0 | 0.036 | -0.024 |